Cargando…

BRAF(V600E )mutations in malignant melanoma are associated with increased expressions of BAALC

BACHGROUND: Activating BRAF mutations are present in approximately 50% of melanomas. Although different downstream target genes of the most common mutant V600E have been identified, the contribution of activating BRAF mutations to malignant transformation needs further clarification. METHODS: Microa...

Descripción completa

Detalles Bibliográficos
Autores principales: Schrama, David, Keller, Gunhild, Houben, Roland, Ziegler, Christian G, Vetter-Kauczok, Claudia S, Ugurel, Selma, Becker, Jürgen C
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483271/
https://www.ncbi.nlm.nih.gov/pubmed/18631381
http://dx.doi.org/10.1186/1477-3163-7-1
_version_ 1782158012767535104
author Schrama, David
Keller, Gunhild
Houben, Roland
Ziegler, Christian G
Vetter-Kauczok, Claudia S
Ugurel, Selma
Becker, Jürgen C
author_facet Schrama, David
Keller, Gunhild
Houben, Roland
Ziegler, Christian G
Vetter-Kauczok, Claudia S
Ugurel, Selma
Becker, Jürgen C
author_sort Schrama, David
collection PubMed
description BACHGROUND: Activating BRAF mutations are present in approximately 50% of melanomas. Although different downstream target genes of the most common mutant V600E have been identified, the contribution of activating BRAF mutations to malignant transformation needs further clarification. METHODS: Microarray gene analysis was performed for human melanoma cell lines harboring BRAF(V600E )mutations in comparison to cell lines without this mutation. RESULTS: This analysis revealed a more than two fold down-regulation of 43 and an increase of 39 gene products. BAALC (Brain and acute Leukaemia, cytoplasmatic) was most prominently regulated, since it was up-regulated in mutated cell lines by a mean of 11.45. Real time PCR analyses with RNA from melanoma cell lines (n = 30) confirmed the BRAF-activation dependent up-regulation of BAALC. CONCLUSION: BAALC, which has been associated with cell dedifferentiation and migration, may function as a downstream effector of activating BRAF mutations during melanomagenesis.
format Text
id pubmed-2483271
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-24832712008-07-28 BRAF(V600E )mutations in malignant melanoma are associated with increased expressions of BAALC Schrama, David Keller, Gunhild Houben, Roland Ziegler, Christian G Vetter-Kauczok, Claudia S Ugurel, Selma Becker, Jürgen C J Carcinog Short Paper BACHGROUND: Activating BRAF mutations are present in approximately 50% of melanomas. Although different downstream target genes of the most common mutant V600E have been identified, the contribution of activating BRAF mutations to malignant transformation needs further clarification. METHODS: Microarray gene analysis was performed for human melanoma cell lines harboring BRAF(V600E )mutations in comparison to cell lines without this mutation. RESULTS: This analysis revealed a more than two fold down-regulation of 43 and an increase of 39 gene products. BAALC (Brain and acute Leukaemia, cytoplasmatic) was most prominently regulated, since it was up-regulated in mutated cell lines by a mean of 11.45. Real time PCR analyses with RNA from melanoma cell lines (n = 30) confirmed the BRAF-activation dependent up-regulation of BAALC. CONCLUSION: BAALC, which has been associated with cell dedifferentiation and migration, may function as a downstream effector of activating BRAF mutations during melanomagenesis. Medknow Publications 2008-07-16 /pmc/articles/PMC2483271/ /pubmed/18631381 http://dx.doi.org/10.1186/1477-3163-7-1 Text en Copyright © 2008 Schrama et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Paper
Schrama, David
Keller, Gunhild
Houben, Roland
Ziegler, Christian G
Vetter-Kauczok, Claudia S
Ugurel, Selma
Becker, Jürgen C
BRAF(V600E )mutations in malignant melanoma are associated with increased expressions of BAALC
title BRAF(V600E )mutations in malignant melanoma are associated with increased expressions of BAALC
title_full BRAF(V600E )mutations in malignant melanoma are associated with increased expressions of BAALC
title_fullStr BRAF(V600E )mutations in malignant melanoma are associated with increased expressions of BAALC
title_full_unstemmed BRAF(V600E )mutations in malignant melanoma are associated with increased expressions of BAALC
title_short BRAF(V600E )mutations in malignant melanoma are associated with increased expressions of BAALC
title_sort braf(v600e )mutations in malignant melanoma are associated with increased expressions of baalc
topic Short Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483271/
https://www.ncbi.nlm.nih.gov/pubmed/18631381
http://dx.doi.org/10.1186/1477-3163-7-1
work_keys_str_mv AT schramadavid brafv600emutationsinmalignantmelanomaareassociatedwithincreasedexpressionsofbaalc
AT kellergunhild brafv600emutationsinmalignantmelanomaareassociatedwithincreasedexpressionsofbaalc
AT houbenroland brafv600emutationsinmalignantmelanomaareassociatedwithincreasedexpressionsofbaalc
AT zieglerchristiang brafv600emutationsinmalignantmelanomaareassociatedwithincreasedexpressionsofbaalc
AT vetterkauczokclaudias brafv600emutationsinmalignantmelanomaareassociatedwithincreasedexpressionsofbaalc
AT ugurelselma brafv600emutationsinmalignantmelanomaareassociatedwithincreasedexpressionsofbaalc
AT beckerjurgenc brafv600emutationsinmalignantmelanomaareassociatedwithincreasedexpressionsofbaalc